Evidence map›Paper›PMID 25504514›Full record

ArticlePurinergic signalling2015

NTPDase2 and the P2Y1 receptor are not required for mammalian eye formation.

Kristine Gampe, Silke Haverkamp, Simon C Robson, Christian Gachet, Laura Hüser, Amparo Acker-Palmer, Herbert Zimmermann

Abstract read
In one paragraph

Article in Purinergic signalling, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. The Healthy and Diseased Retina Seen through Neuron-Glia Interactions.International journal of molecular sciences · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Kristine GampeInstitute of Cell Biology and Neuroscience, Goethe-University, Frankfurt am Main, Max-von-Laue-Str. 13, Germany, k.gampe@bio.uni-frankfurt.de.
Silke Haverkamp
Simon C Robson
Christian Gachet
Laura Hüser
Amparo Acker-Palmer
Herbert Zimmermann
Goethe University Frankfurt · DEMax Planck Institute for Brain Research · DEHarvard University · USInserm · FR

Funding

Engineering Inhibitory Antibodies to Ectoenzymes for Cancer TreatmentR21CA164970 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROBSON, SIMON C. · 2012 to 2013
$405k
NCI NIH HHS R21 CA164970PHS HHS R01 094400
6 · The paper itself

Abstract

Eye formation in vertebrates is controlled by a conserved pattern of molecular networks. Homeobox transcription factors are crucially involved in the establishment and maintenance of the retina. A previous study of Massé et al. (Nature, 449: 1058-62, 2007) using morpholino knockdown identified the ectonucleotidase NTPDase2 and the P2Y1 receptor as essential elements for eye formation in embryos of the clawed frog Xenopus laevis. In order to investigate whether a similarly essential mechanism would be active in mammalian eye development, we analyzed mice KO for Entpd2 or P2ry1 as well as double KO for Entpd2/P2ry1. These mice developed normal eyes. In order to identify potential deficits in the molecular identity or in the arrangement of the cellular elements of the retina, we performed an immunohistological analysis using a variety of retinal markers. The analysis of single and double KO mice demonstrated that NTPDase2 and P2Y1 receptors are not required for murine eye formation, as previously shown for eye development in Xenopus laevis.

Indexed as

Adenosine TriphosphatasesAnimalsEyeMiceMice, KnockoutOrganogenesisReceptors, Purinergic P2Y1RetinaAdenosine TriphosphatasesectoATPaseReceptors, Purinergic P2Y1

Identifiers

PMID25504514
PMCPMC4336302
OpenAlexW2052004158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.